ClinicalTrials.Veeva

Menu

Duct-to-mucosa Versus Invagination for Pancreaticojejunostomy

T

TingBo Liang

Status

Unknown

Conditions

Biliary Tract Neoplasms
Pancreatic Neoplasms

Treatments

Procedure: duct-to-mucosa
Procedure: invagination
Device: Internal stent

Study type

Interventional

Funder types

Other

Identifiers

NCT01695447
ZEH-LL-CX-004-02

Details and patient eligibility

About

The purpose of this study is to determine whether duct-to-mucosa is better than invagination in pancreaticojejunostomy after pancreaticoduodenectomy. This single-centre, open, randomized controlled trail is conducted following ISGPF criteria for pancreatic fistula (PF). The duration of the study is supposed to start from Jan 5th 2012 and last to Dec 2014, until 100 or more cases are accessible. Patients diagnosed with pancreatic cancer, peri-ampullar carcinoma or other benign or malignant diseases which need to operate pancreaticoduodenectomy will be included. Main outcomes are pancreatic fistula rate, mortality, morbidity, reoperation and hospital stay. The investigators assumption that duct-to-mucosa is better than invagination.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients diagnosed with pancreatic cancer or other diseases which need pancreaticoduodenectomy and pancreaticojejunostomy
  • 18 to 80 y/o
  • Operation-tolerated
  • Informed consent

Exclusion criteria

  • History of gastrointestinal operation
  • Pancreaticoduodenectomy is given up during operation
  • Pancreatic duct is difficult to locate
  • Patients require to exit from the study anytime

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

100 participants in 2 patient groups

duct-to-mucosa
Experimental group
Description:
duct-to-mucosa technique is used for pancreaticojejunostomy after pancreaticoduodenectomy
Treatment:
Device: Internal stent
Procedure: duct-to-mucosa
invagination
Active Comparator group
Description:
invagination technique is used for pancreaticojejunostomy after pancreaticoduodenectomy
Treatment:
Device: Internal stent
Procedure: invagination

Trial contacts and locations

1

Loading...

Central trial contact

Xue-Li Bai, Ph.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems